Masimo Co. (NASDAQ:MASI) Given Consensus Recommendation of “Moderate Buy” by Analysts
Shares of Masimo Co. (NASDAQ:MASI – Get Free Report) have received an average rating of “Moderate Buy” from the seven ...
Business Insider17h
Sparian Biosciences Announces Results from the Phase 1 Clinical Trial of First in Class Novel Arylepoxamide Receptor (AEAr) Agonist Analgesic SBS-1000
In particular, respiratory parameters including respiratory rate, pulse oximetry and end tidal CO2 were maintained ... therapies to address significant medical needs. The company was co-founded by ...
The Brighterside of News on MSN8h
AI breakthrough revolutionizes noninvasive brain pressure monitoring
Intracranial hypertension—elevated pressure within the skull—poses life-threatening risks, including strokes, hemorrhages, ...
Upstream5h
Pertamina implements CO2-EOR trial at producing oilfield in Indonesia
Indonesia’s national oil company Pertamina is conducting the field trial of the carbon dioxide enhanced oil recovery (CO ...
Medscape16h
Continuous Glucose Monitors for All? Opinions Remain Mixed
The question is more urgent as over-the-counter continuous glucose monitoring devices become more widely available.
Too Old to Operate16h
Transcutaneous CO2 Monitoring Reduces Elevation and Respiratory Acidosis
The following is a summary of "Prospective randomized evaluation of transcutaneous carbon dioxide monitoring during complex electrophysiological procedures under deep sedation: the TRACES trial," ...